{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:44:40Z","timestamp":1787600680786,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473537"],"award-info":[{"award-number":["82473537"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nat Med"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s11418-026-02050-5","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:42:53Z","timestamp":1780436573000},"page":"1152-1167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sappanone A exerted promising therapeutic effects in vitiligo through Wnt5a-mediated noncanonical Wnt signaling"],"prefix":"10.1007","volume":"80","author":[{"given":"Mingming","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meilin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hejuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9968-0023","authenticated-orcid":false,"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"2050_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/s0140-6736(14)60763-7","volume":"386","author":"K Ezzedine","year":"2015","unstructured":"Ezzedine K, Eleftheriadou V, Whitton M, van Geel N (2015) Vitiligo Lancet 386:74\u201384. https:\/\/doi.org\/10.1016\/s0140-6736(14)60763-7","journal-title":"Vitiligo Lancet"},{"key":"2050_CR2","doi-asserted-by":"publisher","first-page":"15011","DOI":"10.1038\/nrdp.2015.11","volume":"1","author":"M Picardo","year":"2015","unstructured":"Picardo M, Dell\u2019Anna ML, Ezzedine K, Hamzavi I, Harris JE, Parsad D, Taieb A (2015) Vitiligo Nat Rev Dis Primers 1:15011. https:\/\/doi.org\/10.1038\/nrdp.2015.11","journal-title":"Vitiligo Nat Rev Dis Primers"},{"key":"2050_CR3","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/jdv.15987","volume":"34","author":"G Dabas","year":"2020","unstructured":"Dabas G, Vinay K, Parsad D, Kumar A, Kumaran MS (2020) Psychological disturbances in patients with pigmentary disorders: a cross-sectional study. J Eur Acad Dermatol Venereol 34:392\u2013399. https:\/\/doi.org\/10.1111\/jdv.15987","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 1","key":"2050_CR4","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1111\/dth.12007","volume":"25","author":"N Teovska Mitrevska","year":"2012","unstructured":"Teovska Mitrevska N, Eleftheriadou V, Guarneri F (2012) Quality of life in vitiligo patients. Dermatol Ther 25(Suppl 1):S28\u201331. https:\/\/doi.org\/10.1111\/dth.12007","journal-title":"Dermatol Ther"},{"key":"2050_CR5","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev-immunol-100919-023531","volume":"38","author":"ML Frisoli","year":"2020","unstructured":"Frisoli ML, Essien K, Harris JE (2020) Vitiligo: Mechanisms of Pathogenesis and Treatment. Annu Rev Immunol 38:621\u2013648. https:\/\/doi.org\/10.1146\/annurev-immunol-100919-023531","journal-title":"Annu Rev Immunol"},{"key":"2050_CR6","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/med.21754","volume":"41","author":"J Chen","year":"2021","unstructured":"Chen J, Li S, Li C (2021) Mechanisms of melanocyte death in vitiligo. Med Res Rev 41:1138\u20131166. https:\/\/doi.org\/10.1002\/med.21754","journal-title":"Med Res Rev"},{"key":"2050_CR7","doi-asserted-by":"publisher","unstructured":"Chang W-L, Ko C-H (2023) The Role of Oxidative Stress in Vitiligo: An Update on Its Pathogenesis and Therapeutic Implications. Cells 12. https:\/\/doi.org\/10.3390\/cells12060936","DOI":"10.3390\/cells12060936"},{"key":"2050_CR8","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41577-023-00894-6","volume":"23","author":"D Tang","year":"2023","unstructured":"Tang D, Kang R, Zeh HJ, Lotze MT (2023) The multifunctional protein HMGB1: 50 years of discovery. Nat Rev Immunol 23:824\u2013841. https:\/\/doi.org\/10.1038\/s41577-023-00894-6","journal-title":"Nat Rev Immunol"},{"key":"2050_CR9","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1111\/bjd.15151","volume":"176","author":"JY Kim","year":"2017","unstructured":"Kim JY, Lee EJ, Seo J, Oh SH (2017) Impact of high-mobility group box 1 on melanocytic survival and its involvement in the pathogenesis of vitiligo. Br J Dermatol 176:1558\u20131568. https:\/\/doi.org\/10.1111\/bjd.15151","journal-title":"Br J Dermatol"},{"key":"2050_CR10","doi-asserted-by":"publisher","first-page":"6148","DOI":"10.1111\/jcmm.13895","volume":"22","author":"K Mou","year":"2018","unstructured":"Mou K, Liu W, Miao Y, Cao F, Li P (2018) HMGB1 deficiency reduces H(2) O(2) -induced oxidative damage in human melanocytes via the Nrf2 pathway. J Cell Mol Med 22:6148\u20136156. https:\/\/doi.org\/10.1111\/jcmm.13895","journal-title":"J Cell Mol Med"},{"key":"2050_CR11","doi-asserted-by":"publisher","first-page":"e13226","DOI":"10.1111\/pcmr.13226","volume":"38","author":"L Zhang","year":"2025","unstructured":"Zhang L, Zhang J, Liu S, Shi Z, Zhu Y, Jiang M, Xiang L (2025) Effectiveness and Safety of Oral Compound Glycyrrhizin Followed by Phototherapy for the Treatment of Progressive Vitiligo in Children. Pigment Cell Melanoma Res 38:e13226. https:\/\/doi.org\/10.1111\/pcmr.13226","journal-title":"Pigment Cell Melanoma Res"},{"key":"2050_CR12","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1016\/j.jid.2019.03.1148","volume":"139","author":"T Cui","year":"2019","unstructured":"Cui T, Zhang W, Li S, Chen X, Chang Y, Yi X, Kang P, Yang Y, Chen J, Liu L, Jian Z, Li K, Wang G, Gao T, Song P, Li C (2019) Oxidative Stress-Induced HMGB1 Release from Melanocytes: A Paracrine Mechanism Underlying the Cutaneous Inflammation in Vitiligo. J Invest Dermatol 139:2174\u20132184e4. https:\/\/doi.org\/10.1016\/j.jid.2019.03.1148","journal-title":"J Invest Dermatol"},{"key":"2050_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s40257-022-00752-6","volume":"24","author":"KN Cunningham","year":"2023","unstructured":"Cunningham KN, Rosmarin D (2023) Vitiligo Treatments: Review of Current Therapeutic Modalities and JAK Inhibitors. Am J Clin Dermatol 24:165\u2013186. https:\/\/doi.org\/10.1007\/s40257-022-00752-6","journal-title":"Am J Clin Dermatol"},{"key":"2050_CR14","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.7150\/ijbs.96748","volume":"20","author":"J Wang","year":"2024","unstructured":"Wang J, Zhuang H, Yang X, Guo Z, Zhou K, Liu N, An Y, Chen Y, Zhang Z, Wang M, Chen J, Li C, Chang X (2024) Exploring the Mechanism of Ferroptosis Induction by Sappanone A in Cancer: Insights into the Mitochondrial Dysfunction Mediated by NRF2\/xCT\/GPX4 Axis. Int J Biol Sci 20:5145\u20135161. https:\/\/doi.org\/10.7150\/ijbs.96748","journal-title":"Int J Biol Sci"},{"key":"2050_CR15","doi-asserted-by":"publisher","first-page":"116020","DOI":"10.1016\/j.jep.2022.116020","volume":"304","author":"YZ Wang","year":"2023","unstructured":"Wang YZ, Wang YL, Che HJ, Jia YH, Wang HF, Zuo LF, Yang K, Li TT, Wang JX (2023) Sappanone A: A natural PDE4 inhibitor with dual anti-inflammatory and antioxidant activities from the heartwood of Caesalpinia sappan L. J Ethnopharmacol 304:116020. https:\/\/doi.org\/10.1016\/j.jep.2022.116020","journal-title":"J Ethnopharmacol"},{"key":"2050_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2147\/dddt.S230358","volume":"14","author":"X Shi","year":"2020","unstructured":"Shi X, Tao G, Ji L, Tian G (2020) Sappanone A Protects Against Myocardial Ischemia Reperfusion Injury by Modulation of Nrf2. Drug Des Devel Ther 14:61\u201371. https:\/\/doi.org\/10.2147\/dddt.S230358","journal-title":"Drug Des Devel Ther"},{"key":"2050_CR17","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/pcmr.12949","volume":"34","author":"J Seneschal","year":"2021","unstructured":"Seneschal J, Boniface K, D\u2019Arino A, Picardo M (2021) An update on Vitiligo pathogenesis. Pigment Cell Melanoma Res 34:236\u2013243. https:\/\/doi.org\/10.1111\/pcmr.12949","journal-title":"Pigment Cell Melanoma Res"},{"key":"2050_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/jd9.0000000000000151","volume":"4","author":"T-C Lei","year":"2021","unstructured":"Lei T-C, Xu A-E, Gao T-W, He L, Gu H, Li M, Li T-N, Li C-Y, Lin T, Mu K-H, Tu C-X, Wen H, Wu J-Y, Zhang J-L, Zhen Z-Z (2021) Consensus on the Diagnosis and Treatment of Vitiligo in China (2021 Revision)#. Int J Dermatology Venereol 4:10\u201315. https:\/\/doi.org\/10.1097\/jd9.0000000000000151","journal-title":"Int J Dermatology Venereol"},{"key":"2050_CR19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1056\/NEJMc2215181","volume":"388","author":"JC Janssen","year":"2023","unstructured":"Janssen JC, Mulder E, van der Veldt AAM (2023) Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo. N Engl J Med 388:283. https:\/\/doi.org\/10.1056\/NEJMc2215181","journal-title":"N Engl J Med"},{"key":"2050_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.53388\/TMR20230815002","volume":"9","author":"J Liu","year":"2024","unstructured":"Liu J, Li J, Xu J, Li L, Cheng W, Yuan S, Zhang W, Li H (2024) Advances in the function of traditional medicine for vitiligo treatment. Traditional Med Res 9:13\u201318. https:\/\/doi.org\/10.53388\/TMR20230815002","journal-title":"Traditional Med Res"},{"key":"2050_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.freeradbiomed.2012.04.015","volume":"53","author":"B Liu","year":"2012","unstructured":"Liu B, Jian Z, Li Q, Li K, Wang Z, Liu L, Tang L, Yi X, Wang H, Li C, Gao T (2012) Baicalein protects human melanocytes from H\u2082O\u2082-induced apoptosis via inhibiting mitochondria-dependent caspase activation and the p38 MAPK pathway. Free Radic Biol Med 53:183\u2013193. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.04.015","journal-title":"Free Radic Biol Med"},{"key":"2050_CR22","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/jcmm.17711","volume":"27","author":"Y Xie","year":"2023","unstructured":"Xie Y, Mei X, Shi W (2023) Kaempferol promotes melanogenesis and reduces oxidative stress in PIG1 normal human skin melanocytes. J Cell Mol Med 27:982\u2013990. https:\/\/doi.org\/10.1111\/jcmm.17711","journal-title":"J Cell Mol Med"},{"key":"2050_CR23","doi-asserted-by":"publisher","first-page":"18747","DOI":"10.1039\/c8ra09786k","volume":"9","author":"H Zhong","year":"2019","unstructured":"Zhong H, An X, Li Y, Cai M, Ahmad O, Shang J, Zhou J (2019) Sodium tanshinone IIA silate increases melanin synthesis by activating the MAPK and PKA pathways and protects melanocytes from H(2)O(2)-induced oxidative stress. RSC Adv 9:18747\u201318757. https:\/\/doi.org\/10.1039\/c8ra09786k","journal-title":"RSC Adv"},{"key":"2050_CR24","doi-asserted-by":"publisher","first-page":"113560","DOI":"10.1016\/j.intimp.2024.113560","volume":"143","author":"C Deng","year":"2024","unstructured":"Deng C, Sun S, Zhang H, Liu S, Xu X, Hu Y, Ma H, Xin P (2024) Sappanone A attenuates rheumatoid arthritis via inhibiting PI3K\/AKT\/NF-\u03baB and JAK2\/STAT3 signaling pathways in vivo and in vitro. Int Immunopharmacol 143:113560. https:\/\/doi.org\/10.1016\/j.intimp.2024.113560","journal-title":"Int Immunopharmacol"},{"key":"2050_CR25","doi-asserted-by":"publisher","first-page":"176746","DOI":"10.1016\/j.ejphar.2024.176746","volume":"978","author":"H Li","year":"2024","unstructured":"Li H, Xu J, Liu J, Li J, Xu M, Ma P, Li L, Wang Y, Wang C (2024) Sappanone A ameliorated imiquimod-induced psoriasis-like dermatitis in BALB\/c mice via suppressing Mmp8 expression and IL-17 signaling pathway. Eur J Pharmacol 978:176746. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176746","journal-title":"Eur J Pharmacol"},{"key":"2050_CR26","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.intimp.2016.05.019","volume":"38","author":"L Kang","year":"2016","unstructured":"Kang L, Zhao H, Chen C, Zhang X, Xu M, Duan H (2016) Sappanone A protects mice against cisplatin-induced kidney injury. Int Immunopharmacol 38:246\u2013251. https:\/\/doi.org\/10.1016\/j.intimp.2016.05.019","journal-title":"Int Immunopharmacol"},{"key":"2050_CR27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00018-015-2076-y","volume":"73","author":"K Kumawat","year":"2016","unstructured":"Kumawat K, Gosens R (2016) WNT-5A: signaling and functions in health and disease. Cell Mol Life Sci 73:567\u2013587. https:\/\/doi.org\/10.1007\/s00018-015-2076-y","journal-title":"Cell Mol Life Sci"},{"key":"2050_CR28","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s41569-022-00718-5","volume":"19","author":"I Akoumianakis","year":"2022","unstructured":"Akoumianakis I, Polkinghorne M, Antoniades C (2022) Non-canonical WNT signalling in cardiovascular disease: mechanisms and therapeutic implications. Nat Rev Cardiol 19:783\u2013797. https:\/\/doi.org\/10.1038\/s41569-022-00718-5","journal-title":"Nat Rev Cardiol"},{"key":"2050_CR29","doi-asserted-by":"publisher","unstructured":"Akoumianakis I, Sanna F, Margaritis M, Badi I, Akawi N, Herdman L, Coutinho P, Fagan H, Antonopoulos AS, Oikonomou EK, Thomas S, Chiu AP, Chuaiphichai S, Kotanidis CP, Christodoulides C, Petrou M, Krasopoulos G, Sayeed R, Lv L, Hale A, Naeimi Kararoudi M, McNeill E, Douglas G, George S, Tousoulis D, Channon KM, Antoniades C (2019) Adipose tissue-derived WNT5A regulates vascular redox signaling in obesity via USP17\/RAC1-mediated activation of NADPH oxidases. Sci Transl Med 11. https:\/\/doi.org\/10.1126\/scitranslmed.aav5055","DOI":"10.1126\/scitranslmed.aav5055"},{"key":"2050_CR30","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1161\/atvbaha.115.306578","volume":"36","author":"R Bret\u00f3n-Romero","year":"2016","unstructured":"Bret\u00f3n-Romero R, Feng B, Holbrook M, Farb MG, Fetterman JL, Linder EA, Berk BD, Masaki N, Weisbrod RM, Inagaki E, Gokce N, Fuster JJ, Walsh K, Hamburg NM (2016) Endothelial Dysfunction in Human Diabetes Is Mediated by Wnt5a-JNK Signaling. Arterioscler Thromb Vasc Biol 36:561\u2013569. https:\/\/doi.org\/10.1161\/atvbaha.115.306578","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2050_CR31","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2337\/db14-1164","volume":"64","author":"JJ Fuster","year":"2015","unstructured":"Fuster JJ, Zuriaga MA, Ngo DT, Farb MG, Aprahamian T, Yamaguchi TP, Gokce N, Walsh K (2015) Noncanonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion. Diabetes 64:1235\u20131248. https:\/\/doi.org\/10.2337\/db14-1164","journal-title":"Diabetes"}],"container-title":["Journal of Natural Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-026-02050-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11418-026-02050-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-026-02050-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:04:20Z","timestamp":1783605860000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11418-026-02050-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2050"],"URL":"https:\/\/doi.org\/10.1007\/s11418-026-02050-5","relation":{},"ISSN":["1340-3443","1861-0293"],"issn-type":[{"value":"1340-3443","type":"print"},{"value":"1861-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}